HTLV-1 bZIP factor: the key viral gene for pathogenesis

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Human T cell leukemia virus type 1 (HTLV-1) is linked to adult T-cell leukemia-lymphoma (ATL) and inflammatory conditions.
• The HTLV-1 bZIP factor (HBZ) gene is consistently expressed in HTLV-1 infected and ATL cells.

Purpose of the Study:

• To elucidate the multifaceted roles of the HBZ gene, in both protein and RNA forms, in HTLV-1 pathogenesis.
• To understand how HBZ influences the immunophenotype and survival of HTLV-1 infected T cells.

Main Methods:

• Analysis of HBZ protein's transcriptional regulatory functions, including its interaction with transcription factors and coactivators.
• Investigation of HBZ RNA's impact on T cell apoptosis and proliferation.
• Assessment of HBZ's role in immune evasion strategies employed by HTLV-1.

Main Results:

• HBZ protein suppresses the transcription of the tax gene by inhibiting LTR recruitment of ATF/CREB and CBP/p300.
• HBZ promotes the expression of genes such as Foxp3, CCR4, and TIGIT, influencing the infected cells' immunophenotype.
• HBZ RNA actively suppresses apoptosis and enhances T cell proliferation, contributing to viral persistence.

Conclusions:

• HBZ is a critical determinant of the immunophenotype in HTLV-1 infected and ATL cells.
• HBZ, in both protein and RNA forms, plays central roles in maintaining infected T cells in vivo and evading immune surveillance.
• The dual function of HBZ highlights a sophisticated viral strategy for long-term infection and disease progression.